Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences
" "
Safety Alerts
August 17, 1999

Merck and Company Recalls Aminohippurate Sodium Injection

West Point, PA (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Merck and Company is recalling Aminohippurate Sodium Injection because of glass particulate contamination.

Aminohippurate Sodium Injection, 2g in 10 mL (20% Solution) in 10 mL single dose vials, Rx used for the treatment of effective renal plasma flow,(ERPF). NDC #0006-339511.

Recall #D-298-9.

Lot numbers: 0703B EXP May 00, 1498B EXP May 00, 0334D EXP Nov 00, 0839D EXP Nov 00, 0178J EXP Nov 00,1075D EXP Jan 01, 1289D EXP Jan 01, 0035E EXP Jun 01,0035ESA1 EXP Jun 01, 0956E EXP May 02, 1546E EXP May 02,0476H EXP Mar 03, 1111H EXP Mar 03, 1722H EXP Jun 03.

Merck and Company, West Point, Pennsylvania.

Manufacturer, by letter on June 9, 1999. Firm-initiated recall complete.

Nationwide and international.

Firm estimated that 300 units remained at the wholesale level at time of recall initiation.


The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.